United States · Growth startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Safeguard ScientificsLead
Marshall WaceLead
Merck Global Health Innovation Fund
LabCorp
Cigna Ventures
Hikma Ventures
Hunt HoldingsReported by Cigna VenturesSEC filing: $23M sold, first sale Apr 2023
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
These 4 firms list Prognos Health as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Prognos Health's investors include Safeguard Scientifics, Marshall Wace, Merck Global Health Innovation Fund, LabCorp and Cigna Ventures, and 4 more on record. Safeguard Scientifics led its latest round.
Prognos Health has raised $23M across 2 rounds since 2015.
Prognos Health's most recent round was a Growth of $23M in May 2023, led by Safeguard Scientifics.
Its most recent round, $23M in May 2023, is also its largest on record.
Prognos Health's first round on record, in May 2023, was backed by Safeguard Scientifics, Marshall Wace and Merck Global Health Innovation Fund and 6 others.
Prognos Health's latest named round is a Growth, in May 2023.
Prognos Health is based in the United States.
Safeguard Scientifics led the Growth in 2023.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
